FDA Investigator Emir Galevi
Emir Galevi has inspections in 9 countries as of 08 Sep 2023. Emir Galevi has collaborated with a combined 1029 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
353
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China,
United States of America,
Taiwan,
Canada,
Thailand,
Hong Kong,
Malaysia,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Abby E Pelletier,
Alan R Condon,
Amanda S Zorn,
Amy M Cramer,
Andre S Lamontagne,
Andrew J Garufi,
Ashley A Mutawakkil,
Ashley A Segura,
Brenda P King,
Brian R Sweeney,
Catherine J Laufmann,
Craig A Garmendia,
David P Vanhouten,
Dawn M Braswell,
Dawn M Mccabe,
Dennis R Hock,
Dominic R Frasca,
Don A Leeseberg,
Elizabeth B Griffin,
Elmiloudi M Sarhrani,
Francis J Eng,
Francis Pham,
Gary L Zaharek,
George T Allen, Jr,
Gregory M Bessette,
Guozhou Mo,
James E Frye,
James H Tanner,
James W Whitney,
Jason A Rossi,
John A Sciacchitano,
Jonathan B Lewis,
Joseph C Teixeira,
Joshua J Silvestri,
Justina O Tam,
Justine M Corson,
Karen M Rodriguez,
Karen Mcnabb Noon,
Kayla R Huffman,
Laurie B Frazier,
Leo J Lagrotte,
Lisa A Warner,
Lisa D Cash,
Mark K Tseng,
Max Lager,
Michael J Leal,
Michael P Sweeney,
Nabil Nakhoul,
Nassim Ben Makhlouf,
Nydia E Colon,
Philip H Lafleur,
Preston M Lee,
Ronald Ifraimov,
Sandra P White,
Seth A Mailhot,
Stephen C Smith,
Stephen D Eich,
Suzie L Kent,
Teresa I Navas,
Tina A Desorcy,
William K Dagley
Emir Galevi's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2020 | FDA 483 | Mevion Medical Systems, Inc. - Form 483, 2020-03-05 |
January, 2020 | FDA 483 | NeuroLogica Corporation - Form 483, 2020-01-14 |
August, 2022 | FDA 483 | Omni-Guide Holdings, Inc. - Form 483, 2022-08-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more